SCHEMBL6819115

SCHEMBL6819115

N#CCN1C(=O)CCC1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 3/20 0.48
CHRM4 P08173 3/20 0.48
CHRM5 P08912 3/20 0.48
CHRM1 P11229 3/20 0.48
CHRM3 P20309 3/20 0.48
ALDH1A1 P00352 2/20 0.36
NPSR1 Q6W5P4 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
KMT2A Q03164 2/20 0.32
ATM Q13315 1/20 0.32
LMNA P02545 1/20 0.32
ATAD2 Q6PL18 1/20 0.32
MEN1 O00255 1/20 0.32
TSHR P16473 1/20 0.32
KDM4E B2RXH2 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL278150 0.78 CHRM2 (0.52) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL5810929 0.75 ALDH1A1 (0.42) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL11726006 0.74 CHRM2 (0.48) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL17749049 0.74 CHRM2 (0.48) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL25405933 0.72 KMT2A (0.32) KMT2AATMLMNA
SCHEMBL1692728 0.70 GSK3A (0.46) ALDH1A1NPSR1KMT2AMEN1TSHR
SCHEMBL9031379 0.69 CHRM2 (0.59) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL163174 0.69
SCHEMBL10699322 0.68 MGLL (0.46) ALDH1A1NPSR1CYP1A2CYP2C19KMT2A
SCHEMBL28190184 0.68 GSK3A (0.53) ALDH1A1CYP1A2KMT2ALMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103313968-A Nampt and rock inhibitors ABBVIE LAB 2013-09-18 CN disclosed
WO-2004022536-A1 NEW HETEROCYCLIC AMIDE COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLENMARK PHARMACEUTICALS LIMITED (US) 2004-03-18 WO disclosed
US-4621145-A Process for preparing 5-vinyl-2-pyrrolidinone and intermediates therefor MERRELL DOW PHARMACEUTICALS INC. (US) 1986-11-04 US disclosed
EP-0116257-B1 PROCESS FOR PREPARING 4-AMINO-5-HEXENOIC ACID MERRELL DOW FRANCE ET CIE (FR) 1986-08-27 EP disclosed
EP-0116257-A1 Process for preparing 4-amino-5-hexenoic acid MERRELL DOW FRANCE ET CIE (FR) 1984-08-22 EP disclosed